Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

Dr. Lee Schwartzberg on HER2– HR+ Breast Cancer: Tesetaxel & Capecitabine

Posted by & filed under Uncategorized.

Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »

West’s Director of Research Participated in the Clinical Trials for a COVID-19 Vaccine

Posted by & filed under Uncategorized.

Ari VanderWalde, MD, MPH, Bioeth, West Cancer Center and Research Institute’s Director of Research, stands behind the safety and highly regulated protocols for participants in clinical trials. Dr. VanderWalde recognized the importance and urgency to create a safe and effective vaccine to combat COVID-19. “I had a 50% chance of getting the vaccine and 50%… Read more »

West Physicians Publish a Study on the Establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting

Posted by & filed under Uncategorized.

West physicians Dr. Ari VanderWalde, Dr. Axel Grothey, Dr. Daniel Vaena, Dr. Gregorgy Vidal, Dr. Adam ElNaggar, & Dr. Lee Schwartzberg recently published a study on the establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting.   Abstract In the precision medicine era, molecular testing in advanced cancer is foundational… Read more »

Dr. Gregory Vidal Discusses Use of Patient Registries in Neratinib Study

Posted by & filed under Uncategorized.

Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer.   Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »

OneR and West Cancer Physicians Give Ten Presentations at SABCS

Posted by & filed under Uncategorized.

OneR and West Cancer Physicians Give Ten Presentations at SABCS   OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »

Grothey Published in NEJM for Colorectal Cancer Care

Posted by & filed under Uncategorized.

Axel Grothey, MD   The New England Journal of Medicine (NEJM) has recently published an editorial entitled “Pembrolizumab as first-line therapy in mismatch repair-deficient advanced colorectal cancer: A new standard of care” written by West Cancer Center’s GI Medical Oncology Lead and GI Oncology Clinical Research Director, Dr. Axel Grothey.   Click the link below… Read more »

West Cancer Center & Research Institute, through affiliate OneR & Genentech, Launches New Clinical Trial Targeting Actionable Mutation Study in Cancer

Posted by & filed under Uncategorized.

Matching patient populations with a targetable genomic alteration to a specific investigational study is the aim of a new clinical trial through OneR and Genentech. This partnership will facilitate collaborations on various clinical trials, scientific research and real-world data studies that will advance personalized cancer care at community oncology centers like West. “With too many… Read more »

West Cancer Center Offering New, Safer Radiation Therapy Options for Prostate Cancer Patients

Posted by & filed under Uncategorized.

West Clinic Offering New, Safer Radiation Therapy Options for Prostate Cancer Patients   Prostate cancer is the most common cancer in American men, with more than 183,000 new cases diagnosed each year. More than 60,000 American men opt to treat their prostate cancer with radiation every year, but because of the proximity of the rectum… Read more »

2020 West Oncology Conference at Graceland

Posted by & filed under News, Uncategorized.

The 5th Annual West Oncology Conference at Graceland: Advances in the Business and Science of Oncology Special Updates from COA, ASCO, ASH, ASTRO, and ESMO was a valuable forum for the presentation and discussion of new research findings. Participants were provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer… Read more »

X